Navigation Links
Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
Date:10/27/2008

t. With continued pegloticase therapy beyond 6

months in the GOUT 3 study, the proportion of patients demonstrating a

Complete Response for tophus resolution increased over time in both the

every 2 weeks and every 4 weeks groups. While other clinical

assessments also showed clinical improvements, such as a partial tophus

response, it is only the tophus Complete Response that was pre-

specified as a clinical criterion by which to measure success. It is

very encouraging that many patients, who had a tophus partial response

in the first six months of treatment, developed a Complete Response

over a longer treatment period in GOUT 3.

-- Gout Flares: The GOUT 1 and GOUT 2 pivotal studies assessed the affect

of pegloticase treatment on both an efficacy and safety secondary

endpoints in gout flares. As with all urate-lowering therapies, the

frequency of flares increased upon initiation of pegloticase treatment

as expected. The treatment-failure gout patients in the Phase 3

program had a high frequency of gout flares prior to study entry, as

shown by the approximately 1.7 flares per the initial 3-month period

for the placebo group. In the pooled analyses, pegloticase-induced

increase in gout flares occurred in both treatment groups during Months

1-3 to a frequency of about 2.3 and 2.7 respectively, whereas the

placebo group showed no change in flare frequency during the same 3-

month period.

New data presented at ACR demonstrates that in Months 4-6 patients

administered pegloticase every 2 weeks had a statistically

significant lower flare incidence and frequency compared to placebo

patients in the pooled analysis. Additionally, in Months 4-6, the

pegloticase every 4 weeks group had a frequency of gout flares similar

to placebo indi
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study
2. Intensive Lifestyle Intervention Program for Overweight or Obese Patients with Nonalcoholic Steatohepatitis Reduces Weight and Improves Overall Liver Health
3. UKs NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain
4. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
5. AdvanDxs PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections
6. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
7. Peregrine Pharmaceuticals Reports Progress in Its Phase II Trial of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer
8. Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure
9. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
10. DaVita Treats Thousands of Dialysis Patients in Wake of Hurricane Ike
11. Fujitsu PalmSecure and HT Systems PatientSecure Selected by BayCare Health System to Protect Patient Confidentiality and Prevent Medical Identity Theft
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... and synthetic processes prefer to settle into equilibriuma ... is within the realm of non-equilibrium conditions where ... in energy and phases, such as temperature fluctuations, ... humans to regulate their body temperature, airplanes to ... activity. , But even though these conditions ...
(Date:7/24/2014)... Your cell phone may stay ... battery storage capacity. , New research indicates that ... created at Lawrence Livermore National Laboratory ... carbon components will perform as electrodes. , The ... need for higher-performance batteries. Several key characteristics of ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Three companies ... semi-finalists in Livestrong’s Big C Competition. Out of 700 ... each headed to the semi-final round. In this round ... three-month accelerator program, complete with mentoring from thought-leaders and ... As part of the angelMD commitment to the Livestrong ...
(Date:7/24/2014)... July 24, 2014 WIRB-Copernicus Group ® ... and ethical review services for clinical research, announced ... a division of Richmond, VA ... biosafety and biosecurity consulting firm in ... WCG,s biosafety division – WCG Biosafety™ – will ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Getting More Life out of Lithium-ion Batteries 23 angelMD Startups Make Livestrong Big C Semi-finals 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... in Pharmaceutical Thin Film,Technology -, WARREN, N.J., ... specializing in quick dissolving thin film pharmaceutical products,today ... No. 7,425,292 from the,United States Patent and Trademark ... to issue on September 16, 2008, relates,to the ...
... Calif., Sept. 11 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: ... fourth quarter and year-end financial results on September,16, 2008., ... discuss its financial results.,Details for the fiscal year-end call ... 16, 2008 -- Time: 10:30 a.m. ET, 9:30 ...
... Deliver Yield Benefits and Value to Farmers, LONDON, ... a significant growth opportunity in continuing to create more ... and,breeding, leading to more than doubling the company,s 2007,s ... biotechnology, will,tell investors. Padgette will deliver his remarks as ...
Cached Biology Technology:MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 2MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 3Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit 2Monsanto Sees Growing Opportunity for Biotech Traits Globally 2Monsanto Sees Growing Opportunity for Biotech Traits Globally 3Monsanto Sees Growing Opportunity for Biotech Traits Globally 4
(Date:7/24/2014)... 24, 2014) Scientists at The New York ... step closer to creating a viable cell replacement ... cells. , For the first time, NYSCF ... from skin samples of patients with primary progressive ... protocol to induce these stem cells into becoming ...
(Date:7/24/2014)... two factors that characterize sustainable university and college ... qualified physics teachers. Specifically, one or more faculty ... in combination with institutional motivation and commitment can ... Engineering and Math (STEM) teacher shortages are especially ... way for institutions seeking to increase the number ...
(Date:7/24/2014)... own microbial terroir, meaning the microbial populations found on ... product, creating the final flavor according to research published ... Environmental Microbiology . This is the first time investigators ... , Many sake makers inoculate with both bacteria ... the University of California, Davis, but he and his ...
Breaking Biology News(10 mins):NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Creating sustainable STEM teacher preparation programs 2The microbes make the sake brewery 2
... studied interactions between the loggerhead turtle ( Caretta caretta ) ... water surface, mass beachings, and the effects of climate change ... marine species without causing economic losses for fishermen, the scientists ... carried out by night and in areas more than 35 ...
... EAST LANSING, Mich. A team of Michigan State ... created have uncovered the inner workings of a ... develop new medicines or understand how enzymes repair DNA. ... bacterial enzyme that is important in metabolism. Enzymes in ...
... Copenhagen summit to draft a legally binding agreement on the ... that we will see further rapid changes in the global ... the planet,s most vulnerable species at this time of unprecedented ... on 26 February 2010 in the Journal of Experimental ...
Cached Biology News:How can accidental captures of loggerhead turtles be reduced? 2MSU scientists unlock key enzyme using newly created 'cool' method 2Tackling the challenges of survival in a changing world 2Tackling the challenges of survival in a changing world 3
... involves the optimization of immunostaining. ... of the primary antibody, selection ... (e.g. Alk. Phos., HRP, fluorescence, ... detection, evaluation by light or ...
Request Info...
... 9001:2000 Certified USDA Research Registered OLAW Assured ... Training AALAS Certified Technicians Documentation ... Documentation Upon Request Focus CRP ... all your custom immunology service needs. ...
Request Info...
Biology Products: